Weight Loss Medications: A Guide to GLP-1 & GIP Agonists

An overview of modern weight loss medications that work through the GLP-1 and GIP hormone pathways: how they work, what's available, and what to expect.

What are GLP-1 medications for weight loss?

GLP-1 medications (such as semaglutide and tirzepatide) are injectable drugs that mimic natural gut hormones to reduce appetite, slow digestion, and improve blood sugar control. They are clinically proven to help people lose 15-25% of their body weight.

How GLP-1 Medications Work

GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are hormones naturally produced in your gut after eating. They signal your brain to feel full, slow stomach emptying, and help regulate blood sugar.

GLP-1 receptor agonist medications mimic these natural hormones but last much longer, providing appetite suppression and metabolic benefits throughout the week.

Appetite Reduction

Signals the brain's satiety centers to reduce hunger and food cravings, making it easier to eat smaller portions.

Slower Gastric Emptying

Slows how quickly food leaves the stomach, promoting longer-lasting feelings of fullness after meals.

Improved Metabolic Health

Enhances insulin sensitivity and blood sugar control, reducing cardiovascular risk factors.

Mounjaro (Tirzepatide)

Mounjaro is unique among weight loss medications because it is a dual GIP and GLP-1 receptor agonist, the only medication that targets both hormone pathways simultaneously. This dual mechanism may explain its superior weight loss results in clinical trials.

In the SURMOUNT-1 trial, patients on the highest dose of Mounjaro (15mg) lost an average of 22.5% of their body weight over 72 weeks, making it one of the most effective weight loss medications available.

What is the difference between Mounjaro and Ozempic?

Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors (dual agonist), while Ozempic (semaglutide) targets only GLP-1. In clinical trials, Mounjaro showed greater average weight loss (~22.5% vs ~15%). Mounjaro is delivered via KwikPen with a click-based dosing system.

Mounjaro Key Facts

•Active ingredient: Tirzepatide (dual GIP/GLP-1 receptor agonist)
•Available in 6 strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg
•Administered weekly via KwikPen (60 clicks per dose, 4 doses per pen)
•Average weight loss in trials: 15-22.5% of body weight at 72 weeks

Semaglutide Medications (Ozempic & Wegovy)

Semaglutide is a GLP-1 receptor agonist available under two brand names: Ozempic (for type 2 diabetes) and Wegovy (approved for weight management). Both contain the same active ingredient at different dose ranges.

Ozempic

FDA-approved for type 2 diabetes management. Widely used off-label for weight loss.

Doses: 0.25mg, 0.5mg, 1mg, 2mg (weekly)
Prefilled pen with dial-a-dose mechanism

Wegovy

FDA-approved specifically for chronic weight management in adults with obesity or overweight with weight-related conditions.

Doses: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg (weekly)
Single-use prefilled pen (one dose per pen)

Other Weight Loss Medications

Several other medications in the GLP-1 class are approved or in development for weight management:

Saxenda (Liraglutide)

An older GLP-1 receptor agonist that requires daily injections. Doses range from 0.6mg to 3mg. While effective, it typically produces less weight loss than newer weekly medications (~8% average body weight loss).

Zepbound (Tirzepatide)

The same active ingredient as Mounjaro (tirzepatide), but specifically FDA-approved for chronic weight management. Uses the same dosing strengths (2.5mg to 15mg) and weekly injection schedule.

Common Side Effects

GLP-1 medications share a similar side effect profile, primarily gastrointestinal symptoms that usually improve over time as your body adjusts:

Most common side effects

Nausea (most common, especially during titration)
Diarrhea or constipation
Decreased appetite
Abdominal pain or discomfort
Injection site reactions

Side effects typically improve within 2-4 weeks. Starting at a low dose and titrating slowly helps minimize them. Always consult your healthcare provider if side effects persist.

Frequently Asked Questions

Which weight loss medication is most effective?

In clinical trials, tirzepatide (Mounjaro/Zepbound) has shown the greatest average weight loss at approximately 22.5% of body weight at the highest dose. However, individual results vary significantly, and the best medication for you depends on your health profile and your doctor's recommendation.

Are GLP-1 medications safe long-term?

GLP-1 medications have been used for type 2 diabetes management for over a decade with a well-established safety profile. Long-term weight management studies (2+ years) show sustained benefits. However, as with any medication, you should discuss risks and benefits with your healthcare provider.

Do you need a prescription for weight loss injections?

Yes, all GLP-1 and GIP agonist medications (Mounjaro, Ozempic, Wegovy, etc.) require a prescription from a licensed healthcare provider. They are not available over the counter.

What happens when you stop taking GLP-1 medications?

Studies show that most people regain some weight after stopping GLP-1 medications, as appetite and metabolic effects reverse. Maintaining healthy eating habits and regular exercise can help minimize weight regain. Some patients stay on a maintenance dose long-term.

Calculate your Mounjaro dose

If you're using a Mounjaro KwikPen, our free calculator helps you plan custom doses and dose splitting.

Open Dose Calculator